Emcure Pharmaceuticals Limited, a leading name in India’s pharmaceutical industry, has launched its cutting-edge Formulation Research and Development (R&D) Centre near Tapovan Circle, Ahmedabad. Named the Emcure Research Centre (ERC), this advanced facility is poised to drive innovation in complex drug delivery systems, including sustained-release formulations, liposomal injections, and advanced dermal therapies.
Inaugurated by Gujarat’s Hon’ble Health Minister, Shri Rushikeshbhai Patel, the ERC symbolizes Emcure’s commitment to revolutionizing healthcare through cutting-edge research.
The ERC is equipped with state-of-the-art laboratories and advanced tools, supporting every stage of pharmaceutical development—from pre-formulation studies to large-scale manufacturing. Housing a team of 350 highly skilled professionals, including PhDs, postgraduates, and industry experts, the facility focuses on creating patient-centric drug delivery solutions and enhancing drug bioavailability while adhering to global regulatory standards.
Emcure’s R&D Centre also emphasizes sustainable practices and green chemistry, reinforcing the company’s dedication to environmentally responsible innovation. Beyond driving pharmaceutical advancements, the ERC will generate employment opportunities and foster collaborations with academic institutions, regulatory bodies, and industry leaders.
This new facility cements Gujarat’s position as a hub for pharmaceutical research and innovation. By developing differentiated products for regulated, emerging, and domestic markets, Emcure Pharmaceuticals continues to elevate India’s standing in global healthcare.
